nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—HTR2A—arteriole—type 1 diabetes mellitus	0.0235	0.157	CbGeAlD
Nefazodone—SLC6A2—autonomic nervous system—type 1 diabetes mellitus	0.0168	0.112	CbGeAlD
Nefazodone—Hepatic necrosis—Ramipril—type 1 diabetes mellitus	0.0141	0.034	CcSEcCtD
Nefazodone—Neuralgia—Ramipril—type 1 diabetes mellitus	0.0118	0.0284	CcSEcCtD
Nefazodone—SLC6A3—nerve—type 1 diabetes mellitus	0.0117	0.078	CbGeAlD
Nefazodone—Ageusia—Ramipril—type 1 diabetes mellitus	0.0101	0.0244	CcSEcCtD
Nefazodone—HTR2A—autonomic nervous system—type 1 diabetes mellitus	0.0101	0.0672	CbGeAlD
Nefazodone—SLC6A2—nerve—type 1 diabetes mellitus	0.00944	0.0629	CbGeAlD
Nefazodone—Cough increased—Ramipril—type 1 diabetes mellitus	0.00893	0.0216	CcSEcCtD
Nefazodone—Glossitis—Ramipril—type 1 diabetes mellitus	0.00887	0.0214	CcSEcCtD
Nefazodone—ADRA2A—peripheral nervous system—type 1 diabetes mellitus	0.00856	0.057	CbGeAlD
Nefazodone—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.00794	0.0192	CcSEcCtD
Nefazodone—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.00743	0.0179	CcSEcCtD
Nefazodone—Urine output increased—Ramipril—type 1 diabetes mellitus	0.00739	0.0178	CcSEcCtD
Nefazodone—Lightheadedness—Ramipril—type 1 diabetes mellitus	0.00732	0.0177	CcSEcCtD
Nefazodone—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.00732	0.0177	CcSEcCtD
Nefazodone—HTR2A—peripheral nervous system—type 1 diabetes mellitus	0.00728	0.0485	CbGeAlD
Nefazodone—Polyuria—Ramipril—type 1 diabetes mellitus	0.00676	0.0163	CcSEcCtD
Nefazodone—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.0067	0.0162	CcSEcCtD
Nefazodone—Deafness—Ramipril—type 1 diabetes mellitus	0.00664	0.016	CcSEcCtD
Nefazodone—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.00661	0.0159	CcSEcCtD
Nefazodone—CYP3A7-CYP3A51P—nephron tubule—type 1 diabetes mellitus	0.00659	0.044	CbGeAlD
Nefazodone—Libido decreased—Ramipril—type 1 diabetes mellitus	0.0064	0.0154	CcSEcCtD
Nefazodone—Arthritis—Ramipril—type 1 diabetes mellitus	0.00611	0.0147	CcSEcCtD
Nefazodone—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.00608	0.0147	CcSEcCtD
Nefazodone—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00606	0.0146	CcSEcCtD
Nefazodone—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.00596	0.0144	CcSEcCtD
Nefazodone—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00589	0.0142	CcSEcCtD
Nefazodone—HTR2A—nerve—type 1 diabetes mellitus	0.00567	0.0378	CbGeAlD
Nefazodone—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00548	0.0132	CcSEcCtD
Nefazodone—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00542	0.0131	CcSEcCtD
Nefazodone—ADRA1B—kidney—type 1 diabetes mellitus	0.00535	0.0357	CbGeAlD
Nefazodone—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.00535	0.0129	CcSEcCtD
Nefazodone—Gastritis—Ramipril—type 1 diabetes mellitus	0.00525	0.0127	CcSEcCtD
Nefazodone—Influenza—Ramipril—type 1 diabetes mellitus	0.00513	0.0124	CcSEcCtD
Nefazodone—Asthma—Ramipril—type 1 diabetes mellitus	0.00513	0.0124	CcSEcCtD
Nefazodone—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00513	0.0124	CcSEcCtD
Nefazodone—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.005	0.0121	CcSEcCtD
Nefazodone—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00493	0.0119	CcSEcCtD
Nefazodone—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00473	0.0114	CcSEcCtD
Nefazodone—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00468	0.0113	CcSEcCtD
Nefazodone—Weight increased—Ramipril—type 1 diabetes mellitus	0.00467	0.0113	CcSEcCtD
Nefazodone—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00454	0.0109	CcSEcCtD
Nefazodone—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00446	0.0108	CcSEcCtD
Nefazodone—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00445	0.0107	CcSEcCtD
Nefazodone—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00445	0.0107	CcSEcCtD
Nefazodone—Sweating—Ramipril—type 1 diabetes mellitus	0.00439	0.0106	CcSEcCtD
Nefazodone—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00432	0.0104	CcSEcCtD
Nefazodone—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00429	0.0104	CcSEcCtD
Nefazodone—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00411	0.00991	CcSEcCtD
Nefazodone—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00405	0.00976	CcSEcCtD
Nefazodone—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00396	0.00955	CcSEcCtD
Nefazodone—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.00388	0.00937	CcSEcCtD
Nefazodone—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00383	0.00924	CcSEcCtD
Nefazodone—Flushing—Ramipril—type 1 diabetes mellitus	0.00381	0.0092	CcSEcCtD
Nefazodone—Aripiprazole—CHRM2—type 1 diabetes mellitus	0.00369	0.231	CrCbGaD
Nefazodone—Alopecia—Ramipril—type 1 diabetes mellitus	0.00363	0.00876	CcSEcCtD
Nefazodone—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.0035	0.00845	CcSEcCtD
Nefazodone—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00344	0.00829	CcSEcCtD
Nefazodone—CYP3A5—islet of Langerhans—type 1 diabetes mellitus	0.00339	0.0226	CbGeAlD
Nefazodone—Tremor—Ramipril—type 1 diabetes mellitus	0.00335	0.00808	CcSEcCtD
Nefazodone—HTR1A—cardiovascular system—type 1 diabetes mellitus	0.00333	0.0222	CbGeAlD
Nefazodone—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00332	0.008	CcSEcCtD
Nefazodone—Prochlorperazine—CHRM2—type 1 diabetes mellitus	0.00329	0.206	CrCbGaD
Nefazodone—Agitation—Ramipril—type 1 diabetes mellitus	0.00329	0.00793	CcSEcCtD
Nefazodone—Angioedema—Ramipril—type 1 diabetes mellitus	0.00327	0.00788	CcSEcCtD
Nefazodone—ADRA2A—islet of Langerhans—type 1 diabetes mellitus	0.00323	0.0215	CbGeAlD
Nefazodone—Malaise—Ramipril—type 1 diabetes mellitus	0.00322	0.00778	CcSEcCtD
Nefazodone—Vertigo—Ramipril—type 1 diabetes mellitus	0.00321	0.00775	CcSEcCtD
Nefazodone—Syncope—Ramipril—type 1 diabetes mellitus	0.00321	0.00774	CcSEcCtD
Nefazodone—Leukopenia—Ramipril—type 1 diabetes mellitus	0.0032	0.00772	CcSEcCtD
Nefazodone—Palpitations—Ramipril—type 1 diabetes mellitus	0.00316	0.00762	CcSEcCtD
Nefazodone—Aripiprazole—ADRB1—type 1 diabetes mellitus	0.00315	0.197	CrCbGaD
Nefazodone—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00314	0.00758	CcSEcCtD
Nefazodone—Cough—Ramipril—type 1 diabetes mellitus	0.00312	0.00753	CcSEcCtD
Nefazodone—Convulsion—Ramipril—type 1 diabetes mellitus	0.0031	0.00747	CcSEcCtD
Nefazodone—ADRA1A—cardiovascular system—type 1 diabetes mellitus	0.00307	0.0205	CbGeAlD
Nefazodone—Chest pain—Ramipril—type 1 diabetes mellitus	0.00304	0.00734	CcSEcCtD
Nefazodone—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00304	0.00734	CcSEcCtD
Nefazodone—Myalgia—Ramipril—type 1 diabetes mellitus	0.00304	0.00734	CcSEcCtD
Nefazodone—Anxiety—Ramipril—type 1 diabetes mellitus	0.00303	0.00732	CcSEcCtD
Nefazodone—Discomfort—Ramipril—type 1 diabetes mellitus	0.00301	0.00726	CcSEcCtD
Nefazodone—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00298	0.00718	CcSEcCtD
Nefazodone—Confusional state—Ramipril—type 1 diabetes mellitus	0.00294	0.0071	CcSEcCtD
Nefazodone—Oedema—Ramipril—type 1 diabetes mellitus	0.00292	0.00704	CcSEcCtD
Nefazodone—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00292	0.00704	CcSEcCtD
Nefazodone—Shock—Ramipril—type 1 diabetes mellitus	0.00287	0.00693	CcSEcCtD
Nefazodone—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00286	0.00689	CcSEcCtD
Nefazodone—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00285	0.00687	CcSEcCtD
Nefazodone—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00282	0.00681	CcSEcCtD
Nefazodone—Anorexia—Ramipril—type 1 diabetes mellitus	0.00278	0.00671	CcSEcCtD
Nefazodone—CYP3A5—nephron tubule—type 1 diabetes mellitus	0.00273	0.0182	CbGeAlD
Nefazodone—Hypotension—Ramipril—type 1 diabetes mellitus	0.00273	0.00658	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00266	0.00641	CcSEcCtD
Nefazodone—Insomnia—Ramipril—type 1 diabetes mellitus	0.00264	0.00637	CcSEcCtD
Nefazodone—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00262	0.00632	CcSEcCtD
Nefazodone—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.0026	0.00628	CcSEcCtD
Nefazodone—Somnolence—Ramipril—type 1 diabetes mellitus	0.00259	0.00626	CcSEcCtD
Nefazodone—ADRA1A—lymphoid tissue—type 1 diabetes mellitus	0.00258	0.0172	CbGeAlD
Nefazodone—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00257	0.0062	CcSEcCtD
Nefazodone—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00254	0.00612	CcSEcCtD
Nefazodone—Constipation—Ramipril—type 1 diabetes mellitus	0.0025	0.00602	CcSEcCtD
Nefazodone—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.0024	0.0058	CcSEcCtD
Nefazodone—CYP3A5—kidney—type 1 diabetes mellitus	0.0024	0.016	CbGeAlD
Nefazodone—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00239	0.00576	CcSEcCtD
Nefazodone—CYP3A5—pancreas—type 1 diabetes mellitus	0.00238	0.0159	CbGeAlD
Nefazodone—Trifluoperazine—CHRM2—type 1 diabetes mellitus	0.00238	0.149	CrCbGaD
Nefazodone—HTR2A—retina—type 1 diabetes mellitus	0.00235	0.0157	CbGeAlD
Nefazodone—Urticaria—Ramipril—type 1 diabetes mellitus	0.00232	0.00559	CcSEcCtD
Nefazodone—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00231	0.00556	CcSEcCtD
Nefazodone—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00231	0.00556	CcSEcCtD
Nefazodone—Quetiapine—CHRM2—type 1 diabetes mellitus	0.00231	0.144	CrCbGaD
Nefazodone—ADRA2A—pancreas—type 1 diabetes mellitus	0.00227	0.0151	CbGeAlD
Nefazodone—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00215	0.00519	CcSEcCtD
Nefazodone—Asthenia—Ramipril—type 1 diabetes mellitus	0.00209	0.00505	CcSEcCtD
Nefazodone—Pruritus—Ramipril—type 1 diabetes mellitus	0.00206	0.00498	CcSEcCtD
Nefazodone—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.002	0.00482	CcSEcCtD
Nefazodone—HTR2A—cardiovascular system—type 1 diabetes mellitus	0.00199	0.0132	CbGeAlD
Nefazodone—HTR2A—kidney—type 1 diabetes mellitus	0.00194	0.013	CbGeAlD
Nefazodone—Dizziness—Ramipril—type 1 diabetes mellitus	0.00193	0.00466	CcSEcCtD
Nefazodone—Vomiting—Ramipril—type 1 diabetes mellitus	0.00186	0.00448	CcSEcCtD
Nefazodone—Rash—Ramipril—type 1 diabetes mellitus	0.00184	0.00444	CcSEcCtD
Nefazodone—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00184	0.00443	CcSEcCtD
Nefazodone—Headache—Ramipril—type 1 diabetes mellitus	0.00183	0.00441	CcSEcCtD
Nefazodone—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.0018	0.012	CbGeAlD
Nefazodone—CYP3A4—kidney—type 1 diabetes mellitus	0.0018	0.012	CbGeAlD
Nefazodone—CYP2D6—kidney—type 1 diabetes mellitus	0.00177	0.0118	CbGeAlD
Nefazodone—Nausea—Ramipril—type 1 diabetes mellitus	0.00173	0.00418	CcSEcCtD
Nefazodone—ABCB1—retina—type 1 diabetes mellitus	0.00154	0.0103	CbGeAlD
Nefazodone—ABCB1—nephron tubule—type 1 diabetes mellitus	0.00145	0.00967	CbGeAlD
Nefazodone—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.0013	0.00868	CbGeAlD
Nefazodone—ABCB1—kidney—type 1 diabetes mellitus	0.00127	0.00849	CbGeAlD
Nefazodone—ABCB1—pancreas—type 1 diabetes mellitus	0.00127	0.00844	CbGeAlD
Nefazodone—Thioproperazine—ALB—type 1 diabetes mellitus	0.0012	0.0748	CrCbGaD
Nefazodone—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.00109	0.0073	CbGeAlD
Nefazodone—ADRA2A—Metabolism—APOC3—type 1 diabetes mellitus	0.000105	0.000251	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000105	0.000251	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000105	0.00025	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—ALB—type 1 diabetes mellitus	0.000105	0.00025	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—GCG—type 1 diabetes mellitus	0.000104	0.000249	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000103	0.000247	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—GSTT1—type 1 diabetes mellitus	0.000103	0.000247	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ITPR3—type 1 diabetes mellitus	0.000103	0.000246	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000102	0.000244	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000102	0.000243	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000101	0.000242	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000101	0.00024	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000101	0.00024	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—NOS3—type 1 diabetes mellitus	0.0001	0.000239	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	9.99e-05	0.000238	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	9.85e-05	0.000235	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—SST—type 1 diabetes mellitus	9.84e-05	0.000234	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	9.79e-05	0.000233	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	9.79e-05	0.000233	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—SST—type 1 diabetes mellitus	9.78e-05	0.000233	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—ADRB1—type 1 diabetes mellitus	9.74e-05	0.000232	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	9.74e-05	0.000232	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—HBA1—type 1 diabetes mellitus	9.71e-05	0.000231	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—APOC3—type 1 diabetes mellitus	9.68e-05	0.000231	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IAPP—type 1 diabetes mellitus	9.68e-05	0.000231	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—APOC3—type 1 diabetes mellitus	9.65e-05	0.00023	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	9.54e-05	0.000227	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—GSTT1—type 1 diabetes mellitus	9.48e-05	0.000226	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—APOC3—type 1 diabetes mellitus	9.48e-05	0.000226	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IAPP—type 1 diabetes mellitus	9.48e-05	0.000226	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	9.41e-05	0.000224	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—SST—type 1 diabetes mellitus	9.37e-05	0.000223	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—ADRB1—type 1 diabetes mellitus	9.33e-05	0.000222	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	9.32e-05	0.000222	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	9.29e-05	0.000221	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	9.27e-05	0.000221	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	9.22e-05	0.00022	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	9.15e-05	0.000218	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	9.13e-05	0.000218	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	9.08e-05	0.000216	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	8.94e-05	0.000213	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	8.86e-05	0.000211	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—CAT—type 1 diabetes mellitus	8.84e-05	0.000211	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	8.82e-05	0.00021	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IAPP—type 1 diabetes mellitus	8.8e-05	0.00021	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—APOC3—type 1 diabetes mellitus	8.8e-05	0.00021	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—GCG—type 1 diabetes mellitus	8.77e-05	0.000209	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—GCG—type 1 diabetes mellitus	8.72e-05	0.000208	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	8.69e-05	0.000207	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—SST—type 1 diabetes mellitus	8.5e-05	0.000203	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—IL2—type 1 diabetes mellitus	8.49e-05	0.000202	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	8.46e-05	0.000202	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	8.44e-05	0.000201	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	8.43e-05	0.000201	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	8.39e-05	0.0002	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—GCG—type 1 diabetes mellitus	8.35e-05	0.000199	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—SST—type 1 diabetes mellitus	8.32e-05	0.000198	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	8.31e-05	0.000198	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	8.29e-05	0.000198	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	8.28e-05	0.000197	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—GCG—type 1 diabetes mellitus	8.24e-05	0.000196	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	8.2e-05	0.000195	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	8.17e-05	0.000195	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—VAV1—type 1 diabetes mellitus	8.15e-05	0.000194	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CXCL10—type 1 diabetes mellitus	8.13e-05	0.000194	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	8.04e-05	0.000192	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—VAV1—type 1 diabetes mellitus	7.8e-05	0.000186	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	7.78e-05	0.000186	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CXCL10—type 1 diabetes mellitus	7.78e-05	0.000186	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SST—type 1 diabetes mellitus	7.73e-05	0.000184	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	7.7e-05	0.000183	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—GCG—type 1 diabetes mellitus	7.57e-05	0.000181	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—GCG—type 1 diabetes mellitus	7.55e-05	0.00018	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	7.45e-05	0.000178	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	7.42e-05	0.000177	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—GCG—type 1 diabetes mellitus	7.42e-05	0.000177	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—TYK2—type 1 diabetes mellitus	7.41e-05	0.000177	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IGF2—type 1 diabetes mellitus	7.38e-05	0.000176	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	7.34e-05	0.000175	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	7.33e-05	0.000175	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	7.29e-05	0.000174	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	7.28e-05	0.000174	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	7.19e-05	0.000171	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	7.15e-05	0.00017	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CD86—type 1 diabetes mellitus	7.15e-05	0.00017	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	7.14e-05	0.00017	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CD86—type 1 diabetes mellitus	7.11e-05	0.000169	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—TYK2—type 1 diabetes mellitus	7.09e-05	0.000169	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	7.08e-05	0.000169	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IGF2—type 1 diabetes mellitus	7.07e-05	0.000168	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	7.06e-05	0.000168	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—CAT—type 1 diabetes mellitus	6.98e-05	0.000166	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	6.93e-05	0.000165	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	6.91e-05	0.000165	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	6.9e-05	0.000165	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—GCG—type 1 diabetes mellitus	6.89e-05	0.000164	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	6.86e-05	0.000164	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	6.83e-05	0.000163	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CD86—type 1 diabetes mellitus	6.81e-05	0.000162	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—IL2—type 1 diabetes mellitus	6.79e-05	0.000162	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	6.78e-05	0.000162	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—E2F1—type 1 diabetes mellitus	6.75e-05	0.000161	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	6.74e-05	0.000161	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	6.63e-05	0.000158	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	6.5e-05	0.000155	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—E2F1—type 1 diabetes mellitus	6.46e-05	0.000154	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	6.44e-05	0.000154	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	6.44e-05	0.000154	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	6.44e-05	0.000153	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	6.42e-05	0.000153	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	6.41e-05	0.000153	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—ERBB3—type 1 diabetes mellitus	6.41e-05	0.000153	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CAT—type 1 diabetes mellitus	6.39e-05	0.000152	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	6.34e-05	0.000151	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCR5—type 1 diabetes mellitus	6.31e-05	0.00015	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	6.3e-05	0.00015	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	6.28e-05	0.00015	CbGpPWpGaD
Nefazodone—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	6.27e-05	0.000149	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	6.25e-05	0.000149	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL2RA—type 1 diabetes mellitus	6.21e-05	0.000148	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	6.2e-05	0.000148	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CD86—type 1 diabetes mellitus	6.17e-05	0.000147	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL2—type 1 diabetes mellitus	6.17e-05	0.000147	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	6.14e-05	0.000146	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CD86—type 1 diabetes mellitus	6.05e-05	0.000144	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCR5—type 1 diabetes mellitus	6.04e-05	0.000144	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.95e-05	0.000142	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.9e-05	0.000141	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	5.9e-05	0.000141	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—INS—type 1 diabetes mellitus	5.87e-05	0.00014	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.86e-05	0.00014	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	5.86e-05	0.00014	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	5.83e-05	0.000139	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	5.77e-05	0.000138	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.74e-05	0.000137	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	5.7e-05	0.000136	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	5.68e-05	0.000135	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CD86—type 1 diabetes mellitus	5.62e-05	0.000134	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.57e-05	0.000133	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.48e-05	0.000131	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.45e-05	0.00013	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.4e-05	0.000129	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—ALB—type 1 diabetes mellitus	5.38e-05	0.000128	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	5.37e-05	0.000128	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	5.37e-05	0.000128	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.36e-05	0.000128	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.36e-05	0.000128	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.33e-05	0.000127	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.28e-05	0.000126	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.24e-05	0.000125	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CD80—type 1 diabetes mellitus	5.21e-05	0.000124	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CD80—type 1 diabetes mellitus	5.19e-05	0.000124	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—NOS3—type 1 diabetes mellitus	5.15e-05	0.000123	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.06e-05	0.000121	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	4.98e-05	0.000119	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CD80—type 1 diabetes mellitus	4.96e-05	0.000118	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	4.93e-05	0.000117	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	4.91e-05	0.000117	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—INS—type 1 diabetes mellitus	4.9e-05	0.000117	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	4.87e-05	0.000116	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	4.82e-05	0.000115	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	4.8e-05	0.000114	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.76e-05	0.000114	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.74e-05	0.000113	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.74e-05	0.000113	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.72e-05	0.000112	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—INS—type 1 diabetes mellitus	4.69e-05	0.000112	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	4.63e-05	0.00011	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	4.55e-05	0.000108	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.54e-05	0.000108	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.51e-05	0.000108	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	4.51e-05	0.000108	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CD80—type 1 diabetes mellitus	4.5e-05	0.000107	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	4.49e-05	0.000107	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	4.41e-05	0.000105	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	4.41e-05	0.000105	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.4e-05	0.000105	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.38e-05	0.000104	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.32e-05	0.000103	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.3e-05	0.000102	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—INS—type 1 diabetes mellitus	4.26e-05	0.000101	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	4.24e-05	0.000101	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—INS—type 1 diabetes mellitus	4.24e-05	0.000101	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.19e-05	9.99e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	4.17e-05	9.93e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.12e-05	9.81e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.11e-05	9.81e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	4.1e-05	9.77e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.1e-05	9.76e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	4.06e-05	9.68e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.03e-05	9.61e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.01e-05	9.56e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ALB—type 1 diabetes mellitus	3.89e-05	9.27e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	3.87e-05	9.23e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.8e-05	9.06e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.74e-05	8.93e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.73e-05	8.9e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.73e-05	8.88e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.72e-05	8.87e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—NOS3—type 1 diabetes mellitus	3.72e-05	8.87e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.67e-05	8.74e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	3.66e-05	8.73e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.65e-05	8.71e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.65e-05	8.7e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.64e-05	8.69e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL2—type 1 diabetes mellitus	3.64e-05	8.68e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.62e-05	8.64e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	3.51e-05	8.37e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.49e-05	8.33e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL2—type 1 diabetes mellitus	3.49e-05	8.31e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.47e-05	8.27e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.46e-05	8.25e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.4e-05	8.09e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—INS—type 1 diabetes mellitus	3.2e-05	7.63e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.17e-05	7.55e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL2—type 1 diabetes mellitus	3.16e-05	7.54e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.15e-05	7.5e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.1e-05	7.4e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	3.1e-05	7.38e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.08e-05	7.35e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.08e-05	7.35e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.07e-05	7.31e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	3.02e-05	7.19e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	2.97e-05	7.08e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	2.94e-05	7e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.93e-05	7e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.88e-05	6.87e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	2.88e-05	6.86e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.86e-05	6.83e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	2.81e-05	6.69e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.8e-05	6.68e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.79e-05	6.64e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	2.77e-05	6.59e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.67e-05	6.36e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.66e-05	6.35e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	2.65e-05	6.31e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.61e-05	6.21e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.42e-05	5.77e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.42e-05	5.77e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.37e-05	5.65e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.2e-05	5.25e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.15e-05	5.13e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL6—type 1 diabetes mellitus	2.14e-05	5.1e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL6—type 1 diabetes mellitus	2.05e-05	4.89e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	1.97e-05	4.7e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.86e-05	4.43e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.82e-05	4.34e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	1.81e-05	4.31e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	1.73e-05	4.12e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.69e-05	4.03e-05	CbGpPWpGaD
